{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:25:43Z","timestamp":1756383943030},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf - Case Rep"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40800-015-0020-6","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T07:33:56Z","timestamp":1446708836000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Colchicine-Induced Acute Neuromyopathy in a Patient Using Concomitant Fluconazole: Case Report and Literature Review"],"prefix":"10.1007","volume":"2","author":[{"given":"Yi-Chia","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chien","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"20_CR1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/ard.54.12.951","volume":"54","author":"J Lascaratos","year":"1995","unstructured":"Lascaratos J. Arthritis in Byzantium (AD 324-1453): unknown information from non-medicinal literature sources. Ann Rheum Dis. 1995;54:951\u20137.","journal-title":"Ann Rheum Dis"},{"key":"20_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-2952(96)00693-4","volume":"53","author":"T Tateshi","year":"1997","unstructured":"Tateshi T, Soucek P, Caraco Y, Guenrerich FP, Wood AJ. Colchicine biotransformation by human liver microsomes: identification of CYP3A4 as the major isoform responsible for colchicine demethylation. Biochem Pharmacol. 1997;53:111\u20136.","journal-title":"Biochem Pharmacol"},{"key":"20_CR3","doi-asserted-by":"crossref","unstructured":"Dodds Ashley E, Lewis R, Lewis JS, Martin C, Andes D. Pharmacology of systemic antifungal agents. Clin Infect Dis. 2006;43:S28\u201339.","DOI":"10.1086\/504492"},{"issue":"6","key":"20_CR4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/RHU.0b013e3181bbbcd7","volume":"15","author":"J McKinnell","year":"2009","unstructured":"McKinnell J, Tayek JA. Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis. J Clin Rheumatol. 2009;15(6):303\u20135.","journal-title":"J Clin Rheumatol."},{"issue":"5","key":"20_CR5","first-page":"204","volume":"66","author":"W Velden van der","year":"2008","unstructured":"van der Velden W, Huussen J, Ter Laak H, de S\u00e9vaux R. Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin. Neth J Med. 2008;66(5):204\u20136.","journal-title":"Neth J Med."},{"key":"20_CR6","doi-asserted-by":"crossref","unstructured":"Alayli G, Cengiz K, Cant\u00fcrk F, Durmu\u015f D, Akyol Y, Menek\u015fe EB. Acute myopathy in a patient with concomitant use of pravastatin and colchicine. Ann Pharmacother. 2005;39(7\u20138):1358\u201361.","DOI":"10.1345\/aph.1E593"},{"issue":"1","key":"20_CR7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/RHU.0b013e3182056042","volume":"17","author":"R Bouqui\u00e9","year":"2011","unstructured":"Bouqui\u00e9 R, Deslandes G, Renaud C, Dailly E, Haloun A, Jolliet P. Colchicine-induced rhabdomyolysis in a heart\/lung transplant patient with concurrent use of cyclosporin, pravastatin, and azithromycin. J Clin Rheumatol. 2011;17(1):28\u201330.","journal-title":"J Clin Rheumatol."},{"key":"20_CR8","doi-asserted-by":"crossref","unstructured":"Hsu WC, Chen WH, Chang MT, Chiu HC. Colchicine-induced acute myopathy in a patient with concomitant use of simvastatin. Clin Neuropharmacol. 2002;25(5):266\u20138.","DOI":"10.1097\/00002826-200209000-00008"},{"issue":"6","key":"20_CR9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5694\/mja12.10333","volume":"197","author":"DH Oh","year":"2012","unstructured":"Oh DH, Chan SQ, Wilson AM. Myopathy and possible intestinal dysfunction in a patient treated with colchicine and simvastatin. Med J Aust. 2012;197(6):332\u20133.","journal-title":"Med J Aust."},{"issue":"1","key":"20_CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10067-007-0696-9","volume":"27","author":"L Francis","year":"2008","unstructured":"Francis L, Bonilla E, Soforo E, Neupane H, Nakhla H, Fuller C, Perl A. Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclosporine after prior exposure to colchicine and simvastatin. Clin Rheumatol. 2008;27(1):129\u201331.","journal-title":"Clin Rheumatol."},{"issue":"6","key":"20_CR11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/mus.20135","volume":"30","author":"SK Baker","year":"2004","unstructured":"Baker SK, Goodwin S, Sur M, Tarnopolsky MA. Cytoskeletal myotoxicity from simvastatin and colchicine. Muscle Nerve. 2004;30(6):799\u2013802.","journal-title":"Muscle Nerve."},{"issue":"5","key":"20_CR12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/RHU.0b013e318156d977","volume":"13","author":"M Justiniano","year":"2007","unstructured":"Justiniano M, Dold S, Espinoza LR. Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine. J Clin Rheumatol. 2007;13(5):266\u20138.","journal-title":"J Clin Rheumatol."},{"issue":"3","key":"20_CR13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00296-007-0435-1","volume":"28","author":"G Sahin","year":"2008","unstructured":"Sahin G, Korkmaz C, Yalcin AU. Which statin should be used together with colchicine? Clinical experience in three patients with nephrotic syndrome due to AA type amyloidosis. Rheumatol Int. 2008;28(3):289\u201391.","journal-title":"Rheumatol Int."},{"key":"20_CR14","doi-asserted-by":"crossref","unstructured":"Atasoyu EM, Evrenkaya TR, Solmazgul E. Possible colchicine rhabdomyolysis in a fluvastatin-treated patient. Ann Pharmacother. 2005 ;39(7\u20138):1368\u20139.","DOI":"10.1345\/aph.1E653"},{"issue":"3","key":"20_CR15","first-page":"147","volume":"74","author":"FM Sarullo","year":"2010","unstructured":"Sarullo FM, Americo L, Di Franco A, Di Pasquale P. Rhabdomyolysis induced by co-administration of fluvastatin and colchicine. Monaldi Arch Chest Dis. 2010;74(3):147\u20139.","journal-title":"Monaldi Arch Chest Dis."},{"issue":"11","key":"20_CR16","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1345\/aph.1C028","volume":"36","author":"H Atmaca","year":"2002","unstructured":"Atmaca H, Sayarlioglu H, K\u00fclah E, Demircan N, Akpolat T. Rhabdomyolysis associated with gemfibrozil-colchicine therapy. Ann Pharmacother. 2002;36(11):1719\u201321.","journal-title":"Ann Pharmacother."},{"key":"20_CR17","doi-asserted-by":"crossref","unstructured":"Tufan A, Dede DS, Cavus S, Altintas ND, Iskit AB, Topeli A. Rhabdomyolysis in a patient treated with colchicine and atorvastatin. Ann Pharmacother. 2006;40(7\u20138):1466\u20139.","DOI":"10.1345\/aph.1H064"},{"issue":"6","key":"20_CR18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.neuro.2006.09.003","volume":"27","author":"J Torgovnick","year":"2006","unstructured":"Torgovnick J, Sethi N, Arsura E. Colchicine and HMG Co-A reductase inhibitors induced myopathy: a case report. Neurotoxicology. 2006;27(6):1126\u20137.","journal-title":"Neurotoxicology."},{"issue":"2","key":"20_CR19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3346\/jkms.1997.12.2.160","volume":"12","author":"BI Lee","year":"1997","unstructured":"Lee BI, Shin SJ, Yoon SN, Choi YJ, Yang CW, Bang BK. Acute myopathy induced by colchicine in a cyclosporine-treated renal transplant recipient: a case report and review of the literature. J Korean Med Sci. 1997;12(2):160\u20131.","journal-title":"J Korean Med Sci."},{"issue":"5","key":"20_CR20","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/S0041-1345(99)00292-4","volume":"31","author":"L Gruberg","year":"1999","unstructured":"Gruberg L, Har-Zahav Y, Agranat O, Freimark D. Acute myopathy induced by colchicine in a cyclosporine treated heart transplant recipient: possible role of the multidrug resistance transporter. Transplant Proc. 1999;31(5):2157\u20138.","journal-title":"Transplant Proc."},{"issue":"9","key":"20_CR21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/15563650701779703","volume":"46","author":"G Eleftheriou","year":"2008","unstructured":"Eleftheriou G, Bacis G, Fiocchi R, Sebastiano R. Colchicine-induced toxicity in a heart transplant patient with chronic renal failure. Clin Toxicol (Phila). 2008;46(9):827\u201330.","journal-title":"Clin Toxicol (Phila)."},{"issue":"9","key":"20_CR22","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/j.transproceed.2012.09.028","volume":"44","author":"C Garrouste","year":"2012","unstructured":"Garrouste C, Philipponnet C, Kaysi S, Enache I, Tiple A, Heng AE. Severe colchicine intoxication in a renal transplant recipient on cyclosporine. Transplant Proc. 2012;44(9):2851\u20132.","journal-title":"Transplant Proc."},{"issue":"4","key":"20_CR23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0303-8467(97)00092-9","volume":"99","author":"SS Rana","year":"1997","unstructured":"Rana SS, Giuliani MJ, Oddis CV, Lacomis D. Acute onset of colchicine myoneuropathy in cardiac transplant recipients: case studies of three patients. Clin Neurol Neurosurg. 1997;99(4):266\u201370.","journal-title":"Clin Neurol Neurosurg."},{"key":"20_CR24","first-page":"272","volume":"67","author":"FY Khan","year":"2009","unstructured":"Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med. 2009;67:272\u201383.","journal-title":"Neth J Med."},{"key":"20_CR25","first-page":"348","volume":"19","author":"NH Ertel","year":"1971","unstructured":"Ertel NH, Wallace SL. Measurement of colchicine in urine and peripheral leukocytes. Clin Res. 1971;19:348.","journal-title":"Clin Res"},{"key":"20_CR26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1023\/A:1018877803319","volume":"16","author":"RB Kim","year":"1999","unstructured":"Kim RB, Wandel C, Leake B, Cvetkovic M, Fromm MF, Dempsey PJ, et al. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res. 1999;16:408\u201314.","journal-title":"Pharm Res"},{"issue":"1","key":"20_CR27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3349\/ymj.2008.49.1.171","volume":"49","author":"KY Lee","year":"2008","unstructured":"Lee KY, Kim do Y, Chang JY, Bang D. Two cases of acute leukopenia induced by colchicine with concurrent immunosuppressants use in Beh\u00e7et\u2019s disease. Yonsei Med J. 2008;49(1):171\u20133.","journal-title":"Yonsei Med J."},{"key":"20_CR28","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","volume":"316","author":"RW Kuncl","year":"1987","unstructured":"Kuncl RW, Duncan G, Watson D, et al. Colchicine myopathy and neuropathy. N Engl J Med. 1987;316:1562.","journal-title":"N Engl J Med"},{"key":"20_CR29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1345\/aph.1H423","volume":"41","author":"JR Horn","year":"2007","unstructured":"Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674\u201380.","journal-title":"Ann Pharmacother"}],"container-title":["Drug Safety - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40800-015-0020-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40800-015-0020-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40800-015-0020-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:06:32Z","timestamp":1553627192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40800-015-0020-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1007\/s40800-015-0020-6","relation":{},"ISSN":["2199-1162","2198-977X"],"issn-type":[{"value":"2199-1162","type":"print"},{"value":"2198-977X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]},"article-number":"16"}}